Literature DB >> 19755221

Intracardiac echocardiography during interventional procedures.

Sophia Vaina1, Jurgen Ligthart, Maniyal Vijayakumar, Folkert J Ten Cate, Maarten Witsenburg, Luc J Jordaens, George Sianos, Andrew S Thornton, Marcoen F Scholten, Peter de Jaegere, Patrick W Serruys.   

Abstract

BACKGROUND: As non-surgical percutaneous interventions are increasingly considered for many cardiac conditions, high quality near field continuous imaging is warranted, in order to optimize the results, and to prevent and detect complications. Transesophageal echocardiography is the standard imaging technique, however general anesthesia and endotracheal intubation is required during prolonged monitoring of percutaneous interventions. Intracardiac echocardiography is a novel emerging tool that allows a view within the cardiac chambers and the large vessels and can be employed by the interventional cardiologist.
METHOD: In our department, a phased array, multi-frequency, four-way steerable catheter (AcuNaV - Siemens) was used for anatomic and haemodynamic cardiac assessment and for guidance and monitoring during non-coronary percutaneous interventions. In total 135 patients underwent intracardiac echocardiographic investigation, 4 during diagnostic heart catheterization, 6 during percutaneous coronary intervention with the use of a new left ventricular assist device, the Impella Recover LP 2.5 system, 26 during percutaneous transluminal septal myocardial ablation (10 patients were reevaluated with intracardiac echocardiography at 6 months), 50 during interatrial communication closure, 4 during percutaneous left atrial appendage transcatheter occlusion, 7 during percutaneous balloon valvuloplasty, 1 during percutaneous aortic valve replacement and 27 during pulmonary vein ablation. All patients tolerated the procedure very well with no catheter related complications. However, there were two complications, which were due to the guidewire and the sheath, an inferior vena cava dissection and a femoral vein dissection, respectively.
CONCLUSION: Phased array intracardiac imaging is a safe technology, which facilitates non-surgical interventions by providing high quality images. It eliminates the need for general anesthesia and thus increases the patient comfort.

Entities:  

Year:  2006        PMID: 19755221

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  First in vivo use of a capacitive micromachined ultrasound transducer array-based imaging and ablation catheter.

Authors:  Douglas N Stephens; Uyen T Truong; Amin Nikoozadeh; Omer Oralkan; Chi Hyung Seo; Jonathan Cannata; Aaron Dentinger; Kai Thomenius; Alan de la Rama; Tho Nguyen; Feng Lin; Pierre Khuri-Yakub; Aman Mahajan; Kalyanam Shivkumar; Matt O'Donnell; David J Sahn
Journal:  J Ultrasound Med       Date:  2012-02       Impact factor: 2.153

2.  Intra-cardiac echocardiography-guided stent implantation into stenosed superior vena cava in a patient with a history of contrast anaphylaxis.

Authors:  Hironaga Yoshimoto; Kenji Suda; Shintaro Kishimoto; Yoshiyuki Kudo
Journal:  Heart Vessels       Date:  2015-01-21       Impact factor: 2.037

3.  Intracardiac Echocardiography as a Guide for Transcatheter Closure of Patent Ductus Arteriosus.

Authors:  Hironaga Yoshimoto; Maeda Yasuto; Tadashi Inoue; Yoshiyuki Kagiyama; Yozo Teramachi; Ryuta Takase; Yusuke Koteda; Yoshihiro Fukumoto; Motofumi Iemura; Kenji Suda
Journal:  J Interv Cardiol       Date:  2020-07-30       Impact factor: 2.279

4.  Intracardiac acoustic radiation force impulse (ARFI) and shear wave imaging in pigs with focal infarctions.

Authors:  Peter Hollender; David Bradway; Patrick Wolf; Robi Goswami; Gregg Trahey
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2013-08       Impact factor: 2.725

5.  Implantation of Impella CP left ventricular assist device under the guidance of three-dimensional intracardiac echocardiography.

Authors:  Konstantin Yastrebov; Laurencie Brunel; Hugh S Paterson; Zoe A Williams; Innes K Wise; Christopher S Burrows; Paul G Bannon
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.